References
- Anumansirikul N, Wittayasuporn M, Klinubol P, Tachaprutinun A, Wanichwecharungruang SP. UV-screening chitosan nanocontainers: Increasing the photostability of encapsulated materials and controlled release. Nanotechnology 2008; 19: 205101 (9pp)
- Chung Y-C, Chen C-Y. Antibacterial characteristics and activity of acid-soluble chitosan. Bioresource Technol 2008; 99: 2806–2814
- Chung YC, Su YP, Chen CC, Jia G, Wang HL, Wu JCG. Relationship between antibacterial activity of chitosan and surface characteristics of cell wall. Acta Pharmacol Sin 2004; 25: 932–936
- Chung YC, Wang HL, Chen YM, Li SL. Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens. Bioresource Technol 2003; 88: 179–184
- Diaz C, Vargas E, Gätjens-Boniche O. Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines. Int J Pharm 2006; 325: 108–115
- Harish Prashanth KV, Tharanathan RN. Chitin/chitosan: Modifications and their unlimited application potential-an overview. Trends Food Sci Tech 2007; 18: 117–131
- Hjerde RJN, Vårum KM, Grasdalen H, Tokura S, Smidsrød O. Chemical composition of O-(carboxymethyl)-chitins in relation to lysozyme degradation rates. Carbohyd Polym 1997; 34: 131–139
- Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Del Rev 2001; 51: 81–96
- Jang K-I, Lee HG. Stability of chitosan nanoparticles for l-ascorbic acid during heat treatment in aqueous solution. J Agric Food Chem 2008; 56: 1936–1941
- Jiang X, Dai H, Leong KW, Goh SH, Mao HQ, Yang YY. Chitosan-g-PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions. J Gene Med 2006; 8: 477–487
- Kim IY, Seo SJ, Moon HS, Yoo MK, Park IY, Kim BC. Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv 2008; 26: 1–21
- Kristl J, Volk B, Gasperlin M, Sentjurc M, Jurkovic P. Effect of colloidal carriers on ascorbyl palmitate stability. Eur J Pharm Sci 2003; 19: 181–189
- Liu WG, Zhang JR, Cao ZQ, Xu FY, Yao KD. A chitosan-arginine conjugate as a novel anticoagulation biomaterial. J Mater Sci Mater Med 2004; 15: 1199–1203
- Ohya Y, Cai R, Nishizawa H, Hara K, Ouchi T. Preparation of PEG-grafted chitosan nanoparticles as peptide drug carriers. STP Pharma Sci 2000; 10: 77–82
- Qi L, Xu Z, Jiang X, Hu C, Zou X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohyd Res 2004; 339: 2693–2700
- Qin C, Gao J, Wang L, Zeng L, Liu Y. Safety evaluation of short-term exposure to chitooligomers from enzymic preparation. Food Chem Toxicol 2006; 44: 855–861
- Ravi Kumar MNV, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 2004; 25: 1771–1777
- Shi C, Zhu Y, Ran X, Wang M, Su Y, Cheng T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res 2006; 133: 185–192
- Špiclin P, Gasperlin M, Kmetec V. Stability of ascorbyl palmitate in topical microemulsions. Int J Pharm 2001; 222: 271–279
- Üner M, Wissing SA, Yener G, Muller RH. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate. Pharmazie 2005; 60: 577–582
- Vårum KM, Myhr MM, Hjerde RJN, Smidsrød O. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohyd Res 1997; 299: 99–101